United States - English - NLM (National Library of Medicine)

alpha aromatics - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - anitbacterial handwash to help decrease bacteria on the skin stop use if, in rare instances, redness or irrtiation develops. if condition persists for more than 72 hours, consult a physician.

United States - English - NLM (National Library of Medicine)

etailer limited - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic, hand sanitizer decreases bacteria on skin. - in children less than 2 months of age - on open skin wounds - if you are allergic to any of the ingredients stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - bai-hua-she-she-cao 1x chih-shih 1x di-yu 1x hou-pu 1x huai-hua 1x huang-qin 1x jin-yin-hua 1x pu-gong-ying 1x dang-gui 3x - for the temporary relief of mild abdominal discomfort or cramping, bloating, constipation, or diarrhea.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

american chemical and sanitary supply inc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antibacterial antibacterial alcohol wipes

United States - English - NLM (National Library of Medicine)

enchante accessories inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - purpose antiseptic uses to decrease bacteria on the skin that could cause diseases recommended for repeated use

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

forest laboratories uk ltd - sodium dihydrogen phosphate anhydrous; sodium bicarbonate - suppository - 1.69gram ; 1.08gram

Kenya - English - Pharmacy and Poisons Board

103.0 tcid50 of live avian infectious bursal… - injection - 103.0 tcid50 of live avian infectious bursal… - other veterinary immunologicals: other live

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - fenofibrate (unii: u202363uos) (fenofibric acid - unii:bgf9mn2hu1) - fenofibrate 160 mg - fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated ldl-c, total-c, triglycerides and apo b, and to increase hdl-c in adult patients with primary hypercholesterolemia or mixed dyslipidemia (fredrickson types iia and iib). lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate (see national cholesterol education program [ncep] treatment guidelines, below). fenofibrate tablets are also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (fredrickson types iv and v hyperlipidemia). improving glycemic control in diabetic patients showing fasting chylomicronemia will usually reduce fasting triglycerides and eliminate chylomicronemia thereby obviating the need for pharmacologic intervention. markedly elevated levels of serum triglycerides (e.g. >2,000 mg/dl) may increase the risk of developing pancreatitis.

United States - English - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc - piroxicam (unii: 13t4o6vmam) (piroxicam - unii:13t4o6vmam) - piroxicam 10 mg - piroxicam capsules usp is indicated: -   for relief of the signs and symptoms of osteoarthritis. -   for relief of the signs and symptoms of rheumatoid arthritis. piroxicam capsules usp is contraindicated in the following patients: -   known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to piroxicam or any components of the drug product [see warnings and precautions (5.7 , 5.9)] -   history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7 , 5.8)] -   in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1) ] pregnancy category c prior to 30 weeks gestation; category d starting at 30 weeks gestation. risk summary use of nsaids, including piroxicam capsules usp, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosu

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - salsalate (unii: v9mo595c9i) (salsalate - unii:v9mo595c9i) - salsalate 500 mg - carefully consider the potential benefits and risks of salsalate tablets, usp and other treatment options before deciding to use salsalate tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder. salsalate tablet, usp is contraindicated in patients with known hypersensitivity to salsalate. salsalate tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings - anaphylactoid reactions , and precautions - preexisting asthma ). salsalate tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). drug abuse and depen